跳至主要内容
临床试验/IRCT20170417033490N2
IRCT20170417033490N2已完成3 期

Evaluation of oral calcium effect versus placebo in the prevention of moderate to severe OHSS (ovarian hyperstimulation syndrome) in the high-risk patients for OHSS

Tehran University of Medical Sciences0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 45 years(—)
性别
Female

入选标准

  • 1- Antagonist protocol for Assisted reproductive technology (ART)
  • 2- ) 2- The number of follicles = 20 mm is over 20.
  • 3- The plasma estradiol level = 2500pg/ml

排除标准

  • 1-patients with the endocrine disease as Diabetes mellitus, hyperprolactinemia, Cushing disease, congenital adrenal hyperplasia
  • 2- Patients with the systemic disease as asthma, collagen vascular disease, hypercholesterolemia, cycle cell anemia
  • 3- History of neoplasm
  • 4-The plasma estradiol level is high (over 6000pg/ml).
  • 5- Use of insulin-sensitization drugs
  • 6- Patients that were required to the need to cycle cancellation.

研究者

相似试验